GeNeuro Innovation SAS

Quick facts

Phase 2 pipeline

• GNbAC1 · Autoimmune diseases
  GNbAC1 is a recombinant immunoglobulin targeting the human immunoglobulin G1 (IgG1) Fc region.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• GeNeuro Innovation SAS portfolio CI brief
• GeNeuro Innovation SAS pipeline updates RSS